Combining metabolome and clinical indicators with machine learning provides some promising diagnostic markers to precisely detect smear-positive/negative pulmonary tuberculosis
Source check: Source checked. Not independent scientific confirmation.
Finding: The study reports altered fatty-acid and amino-acid metabolite patterns and candidate marker combinations for three TB/control groups; this is a small retrospective biomarker result, not established clinical utility. Primary Methods/Results report 27 smear-positive cases, 37 smear-negative cases and 36 controls; RF performance is checked with SVM and MLP on the same study cohort. Independent external validation is not reported.
Technology: Random forest selects metabolite/clinical feature combinations from plasma metabolomics for smear-positive, smear-negative and control classification.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Random forest selects metabolite/clinical feature combinations from plasma metabolomics for smear-positive, smear-negative and control classification.
- Test and result
- The study reports altered fatty-acid and amino-acid metabolite patterns and candidate marker combinations for three TB/control groups; this is a small retrospective biomarker result, not established clinical utility.
- Limitation / still unknown
- Primary Methods/Results report 27 smear-positive cases, 37 smear-negative cases and 36 controls; RF performance is checked with SVM and MLP on the same study cohort. Independent external validation is not reported.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://link.springer.com/article/10.1186/s12879-022-07694-8
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary source full text Methods and Results; version/date checked against bibliographic record..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.